fludeoxyglucose f18
Generic: fludeoxyglucose f18
Labeler: the feinstein institute for medical researchDrug Facts
Product Profile
Brand Name
fludeoxyglucose f18
Generic Name
fludeoxyglucose f18
Labeler
the feinstein institute for medical research
Dosage Form
INJECTION
Routes
Active Ingredients
fludeoxyglucose f-18 400 mCi/mL
Manufacturer
Identifiers & Regulatory
Product NDC
13267-234
Product ID
13267-234_6586ed67-0b87-4046-a7c1-274d39c10922
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA021870
Listing Expiration
2026-12-31
Marketing Start
2005-08-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
13267234
Hyphenated Format
13267-234
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fludeoxyglucose f18 (source: ndc)
Generic Name
fludeoxyglucose f18 (source: ndc)
Application Number
NDA021870 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mCi/mL
Packaging
- 25 mL in 1 VIAL, GLASS (13267-234-45)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "6586ed67-0b87-4046-a7c1-274d39c10922", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["dfd91498-4bfc-4d45-a9a3-cee6153ae573"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 mL in 1 VIAL, GLASS (13267-234-45)", "package_ndc": "13267-234-45", "marketing_start_date": "20050819"}], "brand_name": "Fludeoxyglucose F18", "product_id": "13267-234_6586ed67-0b87-4046-a7c1-274d39c10922", "dosage_form": "INJECTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "13267-234", "generic_name": "Fludeoxyglucose F18", "labeler_name": "THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose", "brand_name_suffix": "F18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "400 mCi/mL"}], "application_number": "NDA021870", "marketing_category": "NDA", "marketing_start_date": "20050819", "listing_expiration_date": "20261231"}